Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of meetings of the National Center for Advancing Translational Sciences.

The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Cures Acceleration Network Review Board.                    

*Date:*                         September 27, 2018.                    

*Time:*                         8:30 a.m. to 3:00 p.m.                    

*Agenda:*                         Report from the Institute Director.                    

*Place:*                         National Institutes of Health, Building 31, Conference Room 6, 31 Center Drive, Bethesda, MD 20892.                    

*Contact Person:*                         Anna L. Ramsey-Ewing, Ph.D., Executive Secretary, National Center for Advancing Translational Sciences, 1 Democracy Plaza, Room 1072, Bethesda, MD 20892, 301-435-0809,                         *annn.ramseyewing@nih.gov*.                    

*Name of Committee:*                         National Center for Advancing Translational Sciences Advisory Council.                     

*Date:*                         September 27, 2018.                    

*Open:*                         8:30 a.m. to 3:00 p.m.                    

*Agenda:*                         Report from the Institute Director and other staff.                    

*Place:*                         National Institutes of Health, Building 31, Conference Room 6, 31 Center Drive, Bethesda, MD 20892.                    

*Closed:*                         3:15 p.m. to 4:30 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, Building 31, Conference Room 6, 31 Center Drive, Bethesda, MD 20892.                    

*Contact Person:*                         Anna L. Ramsey-Ewing, Ph.D., Executive Secretary, National Center for Advancing Translational Sciences, 1 Democracy Plaza, Room 1072, Bethesda, MD 20892, 301-435-0809,                         *anna.ramseyewing@nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, B—Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS)

Dated: July 5, 2018.

David D. Clary,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2018-14873 Filed 7-11-18; 8:45 am]

 BILLING CODE 4140-01-P